Nasdaq

Trinity Biotech plc Receives Nasdaq Compliance Notice Regarding Bid Price and Market Value Requirements

Trinity Biotech received Nasdaq notices for non-compliance with bid price and market value requirements, with 180 days to address deficiencies. Trinity Biotech plc, a biotechnology company ...
Seeking Alpha

Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2022 Financial Results

To access the replay using an international dial-in number, please see the link below: https://services.choruscall.com/ccforms/replay.html A webcast of the call will ...
KELOLAND News

Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change

DUBLIN, Ireland, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc.(NASDAQ: TRIB) (the “Company”) today announced that it has finalized the effective date of its ratio change of its American ...
Hosted on MSN

Trinity Biotech Announces AGM Results and Board Changes

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest announcement is out from ...
Nasdaq

Trinity Biotech Announces Promising Pre-Pivotal Trial Results for Next-Generation Continuous Glucose Monitoring System

Trinity Biotech plc has announced encouraging results from its recent pre-pivotal clinical trial of its next-generation continuous glucose monitoring (CGM) system, targeting diabetes management. The ...
MarketWatch

Trinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests

The MarketWatch News Department was not involved in the creation of this content. - TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of ...
WFLA News Channel 8

Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance ...

DUBLIN, June 24, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...
NBC4 Columbus

Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process

DUBLIN and PORTLAND, Ore., March 13, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management ...
Morningstar

Trinity Biotech Appoints Paul Tivnan as Non-Executive Director

DUBLIN, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...
WOOD-TV

Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology

DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, ...
BioWorld

Items Tagged with 'Trinity Biotech Plc'

In a sweet indication of an improving capital market for med-tech companies, Biolinq Inc. landed $58 million in bridge financing to support completion of the U.S. pivotal trial of its intradermal ...